Sign in

CIK 0001425205

  • Accelerated filer

IOVANCE BIOTHERAPEUTICS, INC.

Sign in to watch
Ticker
IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
753254381
Phone
+1 650-260-7120
Business address
825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
Former names
Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 99 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-02 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Grant or award · Restricted Stock Units +46,875 46,875
2023-03-02 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Grant or award · Stock Option (right to buy) +93,750 93,750
2023-03-02 BILINSKY IGOR Chief Operating Officer Grant or award · Restricted Stock Units +42,190 42,190
2023-03-02 BILINSKY IGOR Chief Operating Officer Grant or award · Stock Option (right to buy) +84,380 84,380
2023-03-02 Bellemin Jean-Marc Chief Financial Officer Grant or award · Stock Option (right to buy) +168,750 168,750
2023-01-17 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Option exercise +11,248 32,796
2023-01-17 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Shares withheld for taxes −4,678 $6.43 $30K 28,118
2023-01-17 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Option exercise · Restricted Stock Units −11,248 22,502
2023-01-17 BILINSKY IGOR Chief Operating Officer Option exercise +11,248 29,049
2023-01-17 BILINSKY IGOR Chief Operating Officer Shares withheld for taxes −4,671 $6.43 $30K 24,378
2023-01-17 BILINSKY IGOR Chief Operating Officer Option exercise · Restricted Stock Units −11,248 22,502
2023-01-17 Vogt Frederick G Interim CEO & General Counsel Option exercise +83,325 85,325
2023-01-17 Vogt Frederick G Interim CEO & General Counsel Shares withheld for taxes −36,441 $6.43 $234K 48,884
2023-01-17 Vogt Frederick G Interim CEO & General Counsel Option exercise · Restricted Stock Units −83,325 166,675
2023-01-03 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Option exercise +19,690 32,571
2023-01-03 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Shares withheld for taxes −11,023 $6.11 $67K 21,548
2023-01-03 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Option exercise · Restricted Stock Units −19,690 0
2023-01-03 BILINSKY IGOR Chief Operating Officer Option exercise +18,850 28,354
2023-01-03 BILINSKY IGOR Chief Operating Officer Shares withheld for taxes −10,553 $6.11 $64K 17,801
2023-01-03 BILINSKY IGOR Chief Operating Officer Option exercise · Restricted Stock Units −18,850 0

Page 19 of 23 · 446 trades